NL
NL · NL · NL-773d44b56099
Betmiga 50 mg, tabletten met verlengde afgifte
ATC G04BD12
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerAstellas Pharma Europe B.V.
CountryNL (NL)
ATC codeG04BD12
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/12/809
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tablet met verlengde afgifte",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/betmiga-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Mirabegron",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp110670",
"excipients": [
"BUTYLHYDROXYTOLUEEN (E 321)",
"HYPROLOSE (E 463)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE GEEL (E 172)",
"MACROGOL 2000000",
"MACROGOL 8000",
"MAGNESIUMSTEARAAT (E 470b)"
],
"substances": [
"MIRABEGRON"
],
"leaflet_url": null,
"authorised_at": "2012/12/20",
"procedure_number": "EMEA/H/C/002388",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/12/809",
"additional_monitoring": "Y"
}Related drugs
Other records sharing ATC code G04BD12.
Access this data programmatically
Query Betmiga 50 mg, tabletten met verlengde afgifte and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.